ArticleThe Journal of dermatology2025

Is One Year Enough? Extended Adjuvant Dabrafenib Plus Trametinib for Chinese Patients With Resected Stage III Melanoma.

Dong-Dong Jia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.